Background Pancreatic cancer care is complex, and multiple disparities in receipt of
therapies have been documented. The authors aimed to conduct a systematic review of the …

Purpose Pancreatic cancer is a lethal disease. Many patients experience a heavy burden of
cancer-associated symptoms and poor quality of life (QOL). Early palliative care alongside …

Pancreatic cancer is the seventh commonest cause of cancer-related death worldwide.
Although prognosis is poor, both surgery and adjuvant chemotherapy improve survival …

Background Among patients not undergoing curative-intent therapy for esophagogastric
cancer, access to care may vary. We examined the geographic distribution of care delivery …

Background The role of socioeconomic factors as determinants of oncology consultations for
advanced cancers in public payer health care systems is unknown. This study examined the …

Purpose Hospital-based clinical studies have limitations in holistic assessment of cancer
treatment and prognosis, as they omit out-of-hospital patients including elderly individuals …

Abstract Introduction Life‐prolonging therapies (LPTs) are rapidly evolving for the treatment
of advanced prostate cancer, although factors associated with real‐world uptake are not well …

Background Curative intent cancer treatment needs to be balanced with patient
comorbidities and quality of life when treating older women with breast cancer. We …

Background: Little is known about how the geographic distribution of cancer services may
influence disparities in outcomes for noncurable pancreatic adenocarcinoma. We therefore …

Background We describe the association between initial treatment and end-of-life (EOL)
outcomes among patients with pancreatic ductal adenocarcinoma (PDAC). Methods This …